Works matching DE "EZETIMIBE"

Results: 545

Pharmacokinetic comparison between the fixed-dose combination of rosuvastatin/ezetimibe 2.5/10 mg and the co-administration of individual formulations in healthy subjects.

Published in:

Translational & Clinical Pharmacology, 2025, v. 33, n. 2, p. 100, doi. 10.12793/tcp.2025.33.e6

By:

Dowon Lee;
Sejung Hwang;
Taewon Lee;
Kyung-Sang Yu;
SeungHwan Lee

Publication type:

Article

CHEMOMETRIC-ASSISTED SPECTROPHOTOMETRIC AND HPLC METHODS FOR THE SIMULTANEOUS ANALYSIS OF ATORVASTATIN CALCIUM AND EZETIMIBE.

Published in:

Studia Universitatis Babes-Bolyai, Chemia, 2025, v. 70, n. 2, p. 1

By:

DİNÇEL, Aysun;
ER, Nilüfer Burcu;
ONUR, Feyyaz

Publication type:

Article

Statin Plus Ezetimibe Outperforms High-Dose Statins in LDL-C Reduction: Daily Dose.

Published in:

Patient Care (Online), 2024, p. 1

By:

Jennings, Sydney

Publication type:

Article

Combination Statin Plus Ezetimibe More Effective than High-Dose Statin to Reduce LDL-C in People with ASCVD.

Published in:

Patient Care (Online), 2024, p. 1

By:

Halsey, Grace

Publication type:

Article

Bempedoic Acid Should be In Everyone's CVD Prevention Toolbox, According to Steven Nissen, MD.

Published in:

2024

By:

Halsey, Grace

Publication type:

Interview

Steven Nissen, MD, Discusses the "Sweet Spot" for Bempedoic Acid Among Non-Statin Therapies.

Published in:

Patient Care (Online), 2024, p. 1

By:

Halsey, Grace

Publication type:

Article

Analytical quality-by-design approach for development and validation of HPLC method for the simultaneous estimation of omarigliptin, metformin, and ezetimibe: application to human plasma and dosage forms.

Published in:

BMC Chemistry, 2023, v. 17, n. 1, p. 1, doi. 10.1186/s13065-023-00955-w

By:

Magdy, Galal;
Al-enna, Amira A.;
Belal, Fathalla;
El-Domany, Ramadan A.;
Abdel-Megied, Ahmed M.

Publication type:

Article

Burkholderia cenocepacia: a new biocatalyst for efficient bioreduction of ezetimibe intermediate.

Published in:

Journal of Industrial Microbiology & Biotechnology, 2009, v. 36, n. 11, p. 1369, doi. 10.1007/s10295-009-0622-z

By:

Singh, Amit;
Basit, Abdul;
Banerjee, Uttam C.

Publication type:

Article

National Trends in the Use of State-Reimbursed Lipid-Lowering Medications in Latvia (2012–2021).

Published in:

Journal of Clinical Medicine, 2023, v. 12, n. 19, p. 6390, doi. 10.3390/jcm12196390

By:

Praskilevics, Arturs;
Urtane, Inga;
Latkovskis, Gustavs

Publication type:

Article

Effect of High-Intensity Rosuvastatin vs. Combination of Low-Intensity Rosuvastatin and Ezetimibe on HbA1c Levels in Patients without Diabetes: A Randomized IDEAL Trial.

Published in:

Journal of Clinical Medicine, 2023, v. 12, n. 18, p. 6099, doi. 10.3390/jcm12186099

By:

Choe, Jeongcheon;
Lee, Sun-Hack;
Ahn, Jinhee;
Lee, Hyewon;
Oh, Jun-Hyok;
Choi, Junghyun;
Lee, Hancheol;
Cha, Kwangsoo;
Park, Jinsup

Publication type:

Article

Physicochemical characterization of atorvastatin calcium/ezetimibe amorphous nano-solid dispersions prepared by electrospraying method.

Published in:

Artificial Cells, Nanomedicine & Biotechnology, 2017, v. 45, n. 6, p. 1138, doi. 10.1080/21691401.2016.1202262

By:

Jahangiri, Azin;
Barzegar-Jalali, Mohammad;
Javadzadeh, Yousef;
Hamishehkar, Hamed;
Adibkia, Khosro

Publication type:

Article

Pharmacokinetics and bioequivalence of Ezetimibe tablet versus Ezetrol®:an open-label, randomized, two-sequence crossover study in healthy Chinese subjects.

Published in:

BMC Pharmacology & Toxicology, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s40360-023-00649-y

By:

Sun, Feifei;
Liu, Yanping;
Li, Ting;
Lin, Pingping;
Jiang, Xin;
Li, Xin;
Wang, Chenjing;
Gao, Xiaomeng;
Ma, Yaping;
Fu, Yao;
Cao, Yu

Publication type:

Article

Phase 1 Evaluation of the Bioequivalence and Drug‐Drug Interaction Potential of a Novel Fixed‐Dose Combination of Ezetimibe, Atorvastatin, and Amlodipine.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 12, p. 1345, doi. 10.1002/cpdd.1472

By:

Lim, Hyung Soon;
Kim, Jae Hoon;
Hong, Jang Hee;
Jung, Jin‐Gyu;
Sunwoo, Jung

Publication type:

Article

Pharmacokinetics and Bioequivalence of Fixed‐Dose Combination of Simvastatin and Ezetimibe Tablets: A Randomized, Crossover, Open‐Label Study in Healthy Volunteers.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 8, p. 938, doi. 10.1002/cpdd.1411

By:

Leong, Chuei Wuei;
Yee, Kar Ming;
Rani, Tracy Ann;
Lau, Kheng Jinm;
Ahmad, Shahnun;
Amran, Atiqah;
Mohd Hassan, Farah Wahidah;
Kumar, Naveen

Publication type:

Article

Bioequivalence Study of Ezetimibe Tablets After a Single Oral Dose of 10 mg in Healthy Japanese Subjects Under Fasting Conditions.

Published in:

Clinical Pharmacology in Drug Development, 2023, v. 12, n. 7, p. 731, doi. 10.1002/cpdd.1245

By:

Wada, Shigenori;
Sasagane, Yoshiyuki;
Kagatani, Seiya;
Nakagami, Hiroaki

Publication type:

Article

Pharmacokinetic Interaction Among Ezetimibe, Rosuvastatin, and Telmisartan.

Published in:

Clinical Pharmacology in Drug Development, 2021, v. 10, n. 11, p. 1290, doi. 10.1002/cpdd.926

By:

Huh, Ki Young;
Lee, Sang Won;
Lee, Si Beum;
Kim, Kyung Tae;
Jang, In‐Jin;
Lee, SeungHwan

Publication type:

Article

Pharmacokinetic bioequivalence crossover study of branded generic and innovator formulations of the cholesterol lowering agent ezetimibe.

Published in:

Clinical Pharmacology in Drug Development, 2014, v. 3, n. 3, p. 242, doi. 10.1002/cpdd.80

By:

Palmer, Jonathan L.;
Kunhihitlu, Anil;
Costantini, Andrea;
Esquivel, Florencia;
Roush, John;
Edwards, Karina;
Hill, Thomas W.K.

Publication type:

Article

Gene polymorphism and frequencies of the NPC1L1 Gene (rs2072183, rs217434 and rs217428) in Japanese patients with dyslipidemia.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2014, v. 39, n. 5, p. 551, doi. 10.1111/jcpt.12176

By:

Kashiwabara, Y.;
Kobayashi, Y.;
Koba, S.;
Kohyama, N.;
Ohbayashi, M.;
Murayama, J ‐ I.;
Hirano, T.;
Yamamoto, T.

Publication type:

Article

Evaluation of the role of metabolizing enzymes and transporter variants in ezetimibe pharmacokinetics.

Published in:

Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1414059

By:

González-Iglesias, Eva;
Ochoa, Dolores;
Navares-Gómez, Marcos;
Zubiaur, Pablo;
Aldama, Marina;
de la Torre, Tamara;
de los Ríos-Rodríguez, Marta;
Soria-Chacartegui, Paula;
Rodríguez-Lopez, Andrea;
Abad-Santos, Francisco;
Novalbos, Jesús

Publication type:

Article

Evaluation of the effects of ezetimibe on albuminuria and kidney fat in individuals with type 2 diabetes and chronic kidney disease.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 9, p. 2605, doi. 10.1111/dom.15146

By:

Heinrich, Niels Søndergaard;
Pedersen, Rune Ploegstra;
Vestergaard, Mark Bitsch;
Lindberg, Ulrich;
Andersen, Ulrik Bjørn;
Haddock, Bryan;
Hansen, Tine Willum;
Fornoni, Alessia;
Larsson, Henrik Bo Wiberg;
Rossing, Peter

Publication type:

Article

Efficacy and safety of alirocumab among individuals with diabetes mellitus and atherosclerotic cardiovascular disease in the ODYSSEY phase 3 trials.

Published in:

Diabetes, Obesity & Metabolism, 2018, v. 20, n. 10, p. 2389, doi. 10.1111/dom.13384

By:

Ganda, Om P.;
Plutzky, Jorge;
Sanganalmath, Santosh K.;
Bujas‐bobanovic, Maja;
Koren, Andrew;
Mandel, Jonas;
Letierce, Alexia;
Leiter, Lawrence A.

Publication type:

Article

Lipid-lowering efficacy and safety of alirocumab in patients with or without diabetes: A sub-analysis of ODYSSEY COMBO II.

Published in:

Diabetes, Obesity & Metabolism, 2017, v. 19, n. 7, p. 989, doi. 10.1111/dom.12909

By:

Leiter, Lawrence A.;
Zamorano, José Luis;
Bujas‐Bobanovic, Maja;
Louie, Michael J.;
Lecorps, Guillaume;
Cannon, Christopher P.;
Handelsman, Yehuda

Publication type:

Article

Ezetimibe increases intestinal expression of the LDL receptor gene in dyslipidaemic men with insulin resistance.

Published in:

Diabetes, Obesity & Metabolism, 2016, v. 18, n. 12, p. 1226, doi. 10.1111/dom.12749

By:

Drouin‐Chartier, Jean‐Philippe;
Tremblay, André J.;
Lemelin, Valéry;
Lépine, Marie‐Claude;
Lamarche, Benoît;
Couture, Patrick

Publication type:

Article

The efficacy and safety of ezetimibe/simvastatin combination compared with intensified lipid-lowering treatment strategies in diabetic subjects with and without metabolic syndrome.

Published in:

Diabetes, Obesity & Metabolism, 2013, v. 15, n. 6, p. 513, doi. 10.1111/dom.12059

By:

Jimenez, J. G.;
Rosen, J. B.;
Pirags, V.;
Massaad, R.;
Hanson, M. E.;
Brudi, P.;
Triscari, J.

Publication type:

Article

Lipid-altering efficacy and safety profile of combination therapy with ezetimibe/statin vs. statin monotherapy in patients with and without diabetes: an analysis of pooled data from 27 clinical trials.

Published in:

Diabetes, Obesity & Metabolism, 2011, v. 13, n. 7, p. 615, doi. 10.1111/j.1463-1326.2011.01383.x

By:

Leiter, L. A.;
Betteridge, D. J.;
Farnier, M.;
Guyton, J. R.;
Lin, J.;
Shah, A.;
Johnson-Levonas, A. O.;
Brudi, P.

Publication type:

Article

Potential therapeutic uses for ezetimibe beyond lowering LDL-c to decrease cardiovascular events DIABETES, OBESITY AND METABOLISM.

Published in:

Diabetes, Obesity & Metabolism, 2010, v. 12, n. 11, p. 958, doi. 10.1111/j.1463-1326.2010.01261.x

By:

Ahmed, M. H.;
Byrne, C. D.

Publication type:

Article

Long-term efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in hyperlipidaemic patients with diabetes or metabolic syndrome.

Published in:

Diabetes, Obesity & Metabolism, 2010, v. 12, n. 11, p. 983, doi. 10.1111/j.1463-1326.2010.01289.x

By:

Fazio, S.;
Guyton, J. R.;
Lin, J.;
Tomassini, J. E.;
Shah, A.;
Tershakovec, A. M.

Publication type:

Article

Ezetimibe in the Treatment of Patients with Metabolic Diseases.

Published in:

European Endocrinology, 2013, v. 9, n. 1, p. 55, doi. 10.17925/EE.2013.09.01.55

By:

Nehme, Mayssam A.;
Upadhyay, Ashish

Publication type:

Article

Effects of Statin versus the Combination of Ezetimibe plus Statin on Serum Lipid Absorption Markers in Patients with Acute Coronary Syndrome.

Published in:

Journal of Lipids, 2015, v. 2015, p. 1, doi. 10.1155/2015/109158

By:

Watanabe, Erisa;
Yamaguchi, Junichi;
Arashi, Hiroyuki;
Ogawa, Hiroshi;
Hagiwara, Nobuhisa

Publication type:

Article

Ezetimibe: Its Novel Effects on the Prevention and the Treatment of Cholesterol Gallstones and Nonalcoholic Fatty Liver Disease.

Published in:

Journal of Lipids, 2012, p. 1, doi. 10.1155/2012/302847

By:

de Bari, Ornella;
Neuschwander-Tetri, Brent A.;
Liu, Min;
Portincasa, Piero;
Wang, David Q.-H.

Publication type:

Article

Ezetimibe prevents the development of non-alcoholic fatty liver disease induced by high-fat diet in C57BL/6J mice.

Published in:

Molecular Medicine Reports, 2014, v. 10, n. 6, p. 2917, doi. 10.3892/mmr.2014.2623

By:

XIANG WANG;
QIAOHUA REN;
TAO WU;
YONG GUO;
YONG LIANG;
SUBO LIU

Publication type:

Article

Cholesterol-Lowering Drugs as Potential Antivirals: A Repurposing Approach against Flavivirus Infections.

Published in:

Viruses (1999-4915), 2023, v. 15, n. 7, p. 1465, doi. 10.3390/v15071465

By:

Osuna-Ramos, Juan Fidel;
Farfan-Morales, Carlos Noe;
Cordero-Rivera, Carlos Daniel;
De Jesús-González, Luis Adrián;
Reyes-Ruiz, José Manuel;
Hurtado-Monzón, Arianna M.;
Palacios-Rápalo, Selvin Noé;
Jiménez-Camacho, Ricardo;
Meraz-Ríos, Marco Antonio;
Del Ángel, Rosa María

Publication type:

Article

In ASCVD, moderate-intensity statin + ezetimibe was noninferior to high-intensity statin alone at 3 y.

Published in:

2022

By:

Kelsey, Michelle D.;
Newby, L. Kristin

Publication type:

journal article

Recommendations for use of ezetimibe and/or PCSK9 inhibitors in patients with elevated LDL-C.

Published in:

Annals of Internal Medicine, 2022, v. 175, n. 8, p. JC86, doi. 10.7326/J22-0060

By:

Kelsey, Michelle D.;
Newby, L. Kristin

Publication type:

Article

UHPLC Specific Method For Simultaneous Determination of Probable Impurities of Ezetimibe and Simvastatin in Combined Dosage Form.

Published in:

Oriental Journal of Chemistry, 2024, v. 40, n. 1, p. 228, doi. 10.13005/ojc/400128

By:

VADIVELU, ANANTHA LAKSHMI;
VITTAL, SATHAPATHY PANDURANGA;
SURYAKALA, DUVVURI

Publication type:

Article

Identification and Validation of Genotoxic Impurity in Ezetimibe by Reverse Phase High-Performance Liquid Chromatography.

Published in:

Oriental Journal of Chemistry, 2023, v. 39, n. 4, p. 896, doi. 10.13005/ojc/390410

By:

VEERASWAMI, BODDU;
RAMARAO, RAYALA

Publication type:

Article

A case of sitosterolaemia with stomatocyticanaemia and thrombocytopenia treated with Ezetimibe with good response.

Published in:

2013

By:

Ching-ngar Hung;
Ching-yin Lee

Publication type:

Abstract

Effects of short-term add-on ezetimibe to statin treatment on expression of adipokines and inflammatory markers in diabetic and dyslipidemic patients.

Published in:

Cardiovascular Therapeutics, 2017, v. 35, n. 6, p. n/a, doi. 10.1111/1755-5922.12307

By:

Guimarães, Elizandra Silva;
Cerda, Alvaro;
Dorea, Egidio Lima;
Bernik, Marcia Martins Silveira;
Gusukuma, Maria Cecilia;
Pinto, Gelba Almeida;
Fajardo, Cristina Moreno;
Hirata, Mario Hiroyuki;
Hirata, Rosario Dominguez Crespo

Publication type:

Article

Ezetimibe: Use, costs, and adverse events in Australia.

Published in:

Cardiovascular Therapeutics, 2017, v. 35, n. 1, p. 40, doi. 10.1111/1755-5922.12236

By:

Hollingworth, Samantha A.;
Ostini, Remo;
David, Michael C.;
Martin, Jennifer H.;
Tett, Susan E.

Publication type:

Article

Effect of fixed-dose combinations of ezetimibe plus rosuvastatin in patients with primary hypercholesterolemia: MRS-ROZE (Multicenter Randomized Study of ROsuvastatin and eZEtimibe).

Published in:

Cardiovascular Therapeutics, 2016, v. 34, n. 5, p. 371, doi. 10.1111/1755-5922.12213

By:

Kim, Kyung ‐ Jin;
Kim, Sang ‐ Hyun;
Yoon, Young Won;
Rha, Seung ‐ Woon;
Hong, Soon ‐ Jun;
Kwak, Choong ‐ Hwan;
Kim, Weon;
Nam, Chang ‐ Wook;
Rhee, Moo ‐ Yong;
Park, Tae ‐ Ho;
Hong, Taek ‐ Jong;
Park, Sungha;
Ahn, Youngkeun;
Lee, Namho;
Jeon, Hui ‐ Kyung;
Jeon, Dong ‐ Woon;
Han, Kyoo ‐ Rok;
Moon, Keon ‐ Woong;
Chae, In ‐ Ho;
Kim, Hyo ‐ soo

Publication type:

Article

The Effect of Ezetimibe on Androgen Production in Hypercholesterolemic Women with Polycystic Ovary Syndrome.

Published in:

Cardiovascular Therapeutics, 2014, v. 32, n. 5, p. 219, doi. 10.1111/1755-5922.12088

By:

Krysiak, Robert;
Zmuda, Witold;
Okopien, Boguslaw

Publication type:

Article

The Effect of Simvastatin-Ezetimibe Combination Therapy on Adipose Tissue Hormones and Systemic Inflammation in Patients with Isolated Hypercholesterolemia.

Published in:

Cardiovascular Therapeutics, 2014, v. 32, n. 2, p. 40, doi. 10.1111/1755-5922.12057

By:

Krysiak, Robert;
Zmuda, Witold;
Okopien, Bogusław

Publication type:

Article

Lipid-Altering Efficacy of Ezetimibe/Simvastatin 10/20 mg Compared to Rosuvastatin 10 mg in High-Risk Patients with and without Type 2 Diabetes Mellitus Inadequately Controlled Despite Prior Statin Monotherapy.

Published in:

Cardiovascular Therapeutics, 2012, v. 30, n. 2, p. 61, doi. 10.1111/j.1755-5922.2010.00181.x

By:

Vaverkova, Helena;
Farnier, Michel;
Averna, Maurizio;
Missault, Luc;
Viigimaa, Margus;
Dong, Qian;
Shah, Arvind;
Johnson-Levonas, Amy O.;
Brudi, Philippe

Publication type:

Article

Cost-effectiveness of Ezetimibe plus statin lipid-lowering therapy: A systematic review and meta-analysis of cost-utility studies.

Published in:

PLoS ONE, 2022, v. 17, n. 6, p. 1, doi. 10.1371/journal.pone.0264563

By:

Sasidharan, Akhil;
Bagepally, Bhavani Shankara;
Kumar, S. Sajith;
Jagadeesh, Kayala Venkata;
Natarajan, Meenakumari

Publication type:

Article

Comparative safety and efficacy of low- or moderate-intensity statin plus ezetimibe combination therapy and high-intensity statin monotherapy: A meta-analysis of randomized controlled studies.

Published in:

PLoS ONE, 2022, v. 17, n. 3, p. 1, doi. 10.1371/journal.pone.0264437

By:

Ah, Young-Mi;
Jeong, Minseob;
Choi, Hye Duck

Publication type:

Article

First Iranian guidelines for the diagnosis, management, and treatment of hyperlipidemia in adults.

Published in:

Journal of Research in Medical Sciences, 2024, v. 29, p. 1, doi. 10.4103/jrms.jrms_318_23

By:

Kholenjani, Fahimeh Bagheri;
Shahidi, Shahla;
Vaseghi, Golnaz;
Ashoorion, Vahid;
Sarrafzadegan, Nizal

Publication type:

Article

Effects of Ezetimibe, Simvastatin, and their Combination on Inflammatory Parameters in a Rat Model of Adjuvant-Induced Arthritis.

Published in:

Inflammation, 2017, v. 40, n. 2, p. 717, doi. 10.1007/s10753-016-0497-x

By:

Barbosa, Carmem;
Bracht, Lívia;
Ames, Franciele;
Silva-Comar, Francielli;
Tronco, Rafael;
Bersani-Amado, Ciomar

Publication type:

Article

Effects of Simvastatin, Ezetimibe, and Their Combination on Histopathologic Alterations Caused by Adjuvant-Induced Arthritis.

Published in:

Inflammation, 2014, v. 37, n. 4, p. 1035, doi. 10.1007/s10753-014-9826-0

By:

Barbosa, Carmem;
Ritter, Alessandra;
Silva, Lorena;
Grespan, Renata;
Cuman, Roberto;
Hernandes, Luzmarina;
Bersani-Amado, Ciomar

Publication type:

Article

If the IMPROVE-IT Trial Was Positive, as Reported, Why Did the FDA Denied Expanded Approval for Ezetimibe and Simvastatin? An Explanation of the Tipping Point Analysis.

Published in:

2018

By:

Deloughery, Emma P.;
Prasad, Vinay

Publication type:

Editorial

A COUPLED DIFFERENTIAL EQUATION MODEL FOR MULTI-DRUG LIPID LOWERING THERAPY FOR HYPERCHOLESTEROLEMIA.

Published in:

Bulletin: New Jersey Academy of Science, 2010, v. 55, n. 1, p. 19

By:

FEIZABADI, MITRA SHOJANIA;
MARLOWE, THOMAS;
GIARRATANO, STEVEN

Publication type:

Article